USX:MGEN - Miragen Therapeutics Inc (USD 0.461) Miragen Therapeutics Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance

USD 0.461    +0.041 (+9.74%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


9 Apr 2020

Day Change: 0.041 (9.74%)

52 Wk Range: 0.311 - 3.16

Day's Range: 0.4201 - 0.49

Last Volume: 577,831

Current Yield: 0%

Projected Yield: 0%

Open: USD 0.4211

9 Apr 2020

Metric MGEN S.Median
Beta 1.04 0.84
VaR 67.89 25.23
E.Shortfall 94.02 45.03
Liquidity 1.29M 95.2K


9 Apr 2020

PE: -0.342

Market Cap: 14.4M

Price Over Book: 0.621

Price Over Sales: 3.55

Return On Assets: -108.4%

Return On Equity: -181.6%

Price Over NAV: [Friends Only]


CEO: Samuel D. Riccitelli

Headquarters: Carlsbad

Employees: 77

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Signal Genetics, Inc., a commercial stage molecular genetic diagnostic company, focuses on providing diagnostic services that assist physicians in decision making for the care of patients suffering from cancer. The company primarily offers Myeloma Prognostic Risk Signature (MyPRS) test, a microarray-based gene expression profiling assay that tests for the presence of specific groups of genes that could predict low or high level risk of early relapse in patients suffering from multiple myeloma. Signal Genetics, Inc. was founded in 2010 and is headquartered in Carlsbad, California.